AHL Partners LLP - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 174 filers reported holding IMPAX LABORATORIES INC in Q2 2017. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
AHL Partners LLP ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q1 2017$1,432,000
+292.3%
113,238
+311.6%
0.03%
+190.9%
Q4 2016$365,000
-85.8%
27,511
-50.7%
0.01%
-89.2%
Q2 2015$2,563,000
-17.7%
55,814
-16.0%
0.10%
-17.7%
Q1 2015$3,116,000
+80.7%
66,482
+22.1%
0.12%
+39.3%
Q4 2014$1,724,00054,4290.09%
Other shareholders
IMPAX LABORATORIES INC shareholders Q2 2017
NameSharesValueWeighting ↓
Aravt Global 2,670,000$125,143,0009.40%
Krensavage Asset Management, LLC 410,944$19,261,0008.77%
BANBURY PARTNERS LLC 292,660$13,717,0008.70%
Slate Path Capital LP 1,935,000$90,693,0005.72%
BLUE JAY CAPITAL MANAGEMENT, LLC 285,000$13,358,0004.69%
Orbimed Advisors 6,678,000$312,998,0002.67%
Pennant Capital Management, LLC 2,025,000$94,912,0001.78%
Iguana Healthcare Management, LLC 75,000$3,515,0001.48%
Leonard Capital Management, Inc. 89,235$4,182,0001.44%
HUSSMAN STRATEGIC ADVISORS, INC. 250,000$11,718,0001.23%
View complete list of IMPAX LABORATORIES INC shareholders